The EJP RD has launched an Internal Call for Innovation Project in Clinical Trials Methodology in Limited Populations!

The European Joint Programme on Rare Diseases (EJP RD) will implement the present internal (open to EJP RD beneficiaries and their linked third parties) call for collaborative innovation projects to support collaborations among groups of experts (methodological experts, clinicians, patients...) .

The Internal Call for Innovation Project in Clinical Trials Methodology in Limited Populations has been launched on December 7, 2020. The call is open to EJP RD beneficiaries and their linked third parties.

The innovation methodologies topics particularly include (but are not limited to): 

·         Development of a disease progression model from a natural history cohort or other observational studies.

·         Development and validation of a disease specific clinically meaningful outcome with special interest in PCOMs, or composite endpoints.

·         Development of a design and analysis procedure for a pharmacometric model and/or bridging study.

·         Development of a randomization-based model as an alternative analysis strategy and explore the level of evidence.

The call aims to encourage collaborations among groups of experts consisting of different stakeholders including methodological experts, clinicians, patients and industry (when relevant) who will jointly develop innovative ready-to-use methods to enhance RD clinical trial methodologies. 

TIMELINE

• 11 January 2021: A networking meeting will be held to consolidate the collaborative networks.
• 3 March 2021: Foreseen call closing deadline

 To get more information click here: https://www.ejprarediseases.org/index.php/ongoing-calls/innovation-project/

---